Boehringer Ingelheim Pharmaceuticals

Boehringer Ingelheim, founded in 1885 by Albert Boehringer (1861-1939) in Ingelheim, Germany, began with just 28 people employed to manufacture tartaric acid salts. Now, 125 years later we are a global enterprise, employing more than 41,500 people in 50 countries. Our focus is primarily in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology.